Transgenic ungulates capable of human antibody production

A - Human Necessities – 01 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A01K 67/027 (2006.01) C12N 5/10 (2006.01) C12N 15/02 (2006.01) C12N 15/09 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2484655

The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy chain expression and, optionally, by inactivation of Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of xenogenous antibodies (e.g., non-bovine antibodies), preferably human antibodies.

L'invention concerne de nouvelles méthodes de production de grandes quantités d'anticorps xénogéniques, tels que des anticorps humains. Ces grandes quantités d'anticorps sont, de préférence, obtenues par l'inactivation de l'expression de la chaîne lourde des IgM et, éventuellement, par l'inactivation de l'expression de la chaîne légère des Ig et par l'introduction ultérieure d'un chromosome artificiel entraînant l'expression d'anticorps xénogéniques (p. ex. d'anticorps non bovins), de préférence d'anticorps humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transgenic ungulates capable of human antibody production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic ungulates capable of human antibody production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic ungulates capable of human antibody production will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1822369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.